Cryoport CEO exercises options, sells small share block

Cryoport, Inc. President and CEO Jerrell Shelton exercised stock options and completed a small share sale.

Rhea-AI Filing Summary

Cryoport, Inc. President and CEO Jerrell Shelton exercised stock options and completed a small share sale. He exercised options to acquire 25,000 shares of common stock at an exercise price of $1.87 per share. On the same date, he sold 2,894 shares of common stock at $8.18 per share.

According to the disclosure, the sold shares were required to be sold under company policies to pay taxes due upon the vesting of restricted stock rights, making this a tax-driven, rather than discretionary, sale. After these transactions, Shelton directly owned 1,076,607 shares of Cryoport common stock.

Insights

Equity compensation and governance analyst

Routine option exercise and tax-related sale with minor ownership impact.

Cryoport President and CEO Jerrell Shelton exercised options to acquire 25,000 shares of common stock at an exercise price of $1.87 per share, converting derivative compensation into outright equity. This type of transaction is typical for long-term equity incentive plans.

He also sold 2,894 shares at $8.18 per share. A footnote explains these shares were required to be sold under company policies to cover taxes on vested restricted stock rights, indicating a mechanistic, tax-driven sale rather than a discretionary reduction in exposure.

Following the transactions, Shelton held 1,076,607 shares directly, so the sale represents a very small portion of his overall position. Given the limited size and tax-related nature of the sale, this filing is best viewed as routine equity compensation activity rather than a signal of changing sentiment.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider SHELTON JERRELL

Role President, CEO

Sold 2,894 shs ($24K)

Approx. gross sale proceeds $24K

Approx. exercise cost $47K

Type	Security	Shares	Price	Value
Exercise	Options to purchase common stock	25,000	$0.00	$0.00
Sale	Common Stock	2,894	$8.18	$24K
Exercise	Common Stock	25,000	$1.87	$47K

Holdings After Transaction: Options to purchase common stock — 154,007 contracts (Direct); Common Stock — 1,076,607 shares (Direct)

Footnotes (2)

1. F1. Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
2. F2. 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cryoport (CYRX) CEO Jerrell Shelton report in this Form 4 filing?

Jerrell Shelton reported exercising options and a small share sale. He exercised options to acquire 25,000 Cryoport common shares at $1.87 per share and sold 2,894 shares at $8.18 per share, while retaining over 1.07 million shares afterward.

How many Cryoport (CYRX) shares does CEO Jerrell Shelton own after these transactions?

After the reported transactions, Jerrell Shelton directly owns 1,076,607 Cryoport common shares. This figure reflects his position following the 25,000-share option exercise and the sale of 2,894 shares that were used to satisfy tax obligations on vested restricted stock rights.

Were Jerrell Shelton’s Cryoport (CYRX) share sales discretionary or tax-related?

The sale was tax-related rather than discretionary. A footnote states the 2,894 shares were required to be sold under Cryoport policies to pay taxes due upon vesting of restricted stock rights, indicating a mechanistic transaction tied to compensation, not an elective reduction in holdings.

What option exercise did Cryoport (CYRX) CEO Jerrell Shelton complete?

Jerrell Shelton exercised stock options covering 25,000 shares of Cryoport common stock at an exercise price of $1.87 per share. This converted derivative compensation into directly held shares as part of his long-term equity incentives under the company’s option program.

How significant is the Cryoport (CYRX) share sale by CEO Jerrell Shelton?

The sale is small relative to his total holdings. Shelton sold 2,894 shares at $8.18 per share while remaining directly invested in 1,076,607 shares, suggesting the transaction primarily addressed tax obligations rather than a meaningful change in his equity exposure to Cryoport.

What prices were involved in Jerrell Shelton’s Cryoport (CYRX) Form 4 transactions?

Shelton exercised options at an exercise price of $1.87 per Cryoport share and sold 2,894 common shares at $8.18 per share. These prices highlight the conversion of lower-priced option awards into common stock, followed by a small sale tied to tax payment requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/25/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHELTON JERRELL

(Last) (First) (Middle)

C/O CRYOPORT INC.

112 WESTWOOD PLACE, SUITE 350

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/23/2026		S(1)		2,894	D	$8.18	1,051,607	D
Common Stock	03/23/2026		M		25,000	A	$1.87	1,076,607	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock	$1.87	03/23/2026		M			25,000	(2)	05/06/2026	Common Stock	25,000	$0	154,007	D

Explanation of Responses:

1. Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

2. 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

	/s/ Jerrell Shelton	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)